Biomedical Research

Documents

FDA

Reference 10 - Gadolinium-Based Contrast Agent Accumulation and Toxicity

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 11 - On the interaction of muscle actin with gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 12 - Skin-Related Adverse Reactions in Gadolinium-Based Contrast Agents-Induced Hypersensitivity

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 13 - Prepubertal exposure to gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 14 - Contrast-free identification of glioma blood-brain barrier status via generative diffusion AI and non-contrast MRI

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 15 - Gadolinium based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 16 - Immediate adverse reactions to gadolinium-based MR contrast

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 17 - Effects of Salicylate and Lanthanides on Outer Hair Cell Motility

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 18 - Deposition of Gadolinium in the Central and Peripheral Nervous Systems and Its Effects on Sensory

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 19 - Gadolinium-based contrast agent toxicity

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 20 - Human Hair as a Possible Surrogate Marker of Retained Tissue

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 21 - Influence blocking by Gadolinium in Calcium Diffusion

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →